Emelia J. Benjamin
273
Publications
2
Followers
0
Following
0
Questions
About
Emelia J. Benjamin, MD, ScM, is a board-certified cardiologist at Boston Medical Center (BMC) and a Robert Dawson Evans Distinguished Professor of Medicine at Boston University Chobanian & Avedisian School of Medicine. She is also the associate provost for faculty development for Boston University Medical Campus. Dr. Benjamin has authored more than 800 peer-reviewed publications on the genetics, epidemiology, and prognosis of a variety of cardiovascular conditions. A passionate and dedicated mentor, she has won local and national awards for mentoring, education, and research, and she is an active volunteer for the American Heart Association.
Emelia J. Benjamin, MD, ScM, FACC, FAHA, received her AB at Harvard, her MD at Case Western Reserve University, and her Epidemiology ScM at Harvard School of Public Health. She is a Professor of Medicine and Epidemiology at Boston University and is a cardiologist at Boston Medical Center. She is a Robert Dawson Evans Distinguished Professor of Medicine at Chobanian and Avedisian School of Medicine.
She is author of over 800 peer-reviewed publications that focus on the genetics, epidemiology, and prognosis of a variety of cardiovascular conditions and markers including atrial fibrillation, vascular function, and systemic inflammation. She has been continuously NIH funded since 1998, and currently is multi-Principal Investigator on an R01 atrial fibrillation grant [2R01HL092577], several chronic pain grants, and is the Training Director on the Boston University American Heart Association Strategically Focused Research Network on Cardio-Oncology. She is an internationally recognized expert on the epidemiology of atrial fibrillation. Dr. Benjamin has Co-Chaired the NIH National Heart Lung and Blood Institutes’ (NHLBI) Atrial Fibrillation Working Group, which advised the NHLBI’s atrial fibrillation research agenda, and resulted in 6 publications.
Dr. Benjamin has conducted research at the Framingham Study since 1988. She is a Member of the Executive Committee, and is Co-Director of the Medical Endpoints Committee. She was Principal Investigator of the grant that recruited the second generation of the Framingham Study's ethnic/racial minority cohort, the Omni Study.
In addition to her research, she is the inaugural Associate Provost for Faculty Development for Boston University Medical Campus, and the inaugural Vice Chair for Faculty Development and Diversity, BU Department of Medicine. She co-designed and co-leads Faculty Development Programs for Early, Mid-Career, Under-Represented Ethnic and Racial, Women, and Clinical Leaders. In 2023 she completed the Columbia University Advanced Coaching Certification.
A passionate and dedicated mentor, she has won local and national awards for mentoring, education, and research. She was inducted into the Association of American Physicians and she won the 2020 Alliance for Academic Internal Medicine Diversity, Equity, and Inclusion Award.
An active volunteer for the American Heart Association since 1992, she has served on a variety of local and national Committees. She is Past-Chair of the American Heart Association’s Functional Genomics and Translational Biology Council and Study Section, and the annual Heart and Stroke Statistical Update. She received the 2015 Paul Dudley White Award, the 2016 AHA Gold Heart Award, the 2016 Population Research Prize, the 2019 Laennec Clinician/ Educator Lecturer, and the Genomics and Precision Medicine 2019 Distinguished Achievement Award, and the 2022 Distinguished Scientist Award.
Skills & Expertise
Public Health
Medicine
Cardiovascular Disease
Research Leadership
Precision Medicine in Cardiology
Grant Acquisition
Cardiovascular Genetics
Atrial Fibrillation
Chronic Pain Research
Diversity Initiatives
Clinical Education
Research Interests
Epidemiology
Faculty Development
Diversity issues
Prevention
Precision Medicine
cardiovascular disease
Inflammation
cardiologist
atrial fibrillation
vascular function
cardiovascular prevention
Internal Medicine
Cardiovascular Epidemiology
Atrial Fibrillation
Genetics of Cardiovascular Disease
Cardio-Oncology Research
Chronic Pain Research
Mentoring in Medicine
NIH-Funded Research
Vascular Function
Systemic Inflammation
Translational Genomics
Clinical Leadership Development
Atrial fibrillation
Vascular function
Connect With Me
Experience
Professor of Medicine and Epidemiology
Director of Echocardiography and Vascular Testing
- Present the Framingham Heart Study is a longitudinal community-based 3-generation observational cohort study founded in 1948 to study the epidemiology, risk factors and prognosis of cardiovascular disease.
Vice Chair Faculty Development & Diversity
- Present
Assistant Provost for Faculty Development
- Present
Cardiology Fellow
Education
Harvard T.H. Chan School of Public Health, Boston
School of Medicine, Case Western Reserve University
Harvard University
Projects
ENDOTHELIAL VASAMOTOR FUNCTION IN THE FRAMINGHAM STUDY
INFLAMMATION: CORRELATES AND PROGNOSIS IN FRAMINGHAM
Vascular Function in the Framingham Third Generation
Framingham: Inflammation, Genes &Cardiovascular Disease
Aging and Inflammation: Longitudinal Markers and Genetics in the Framingham Study
Identification of Common Genetic Variants for Atrial Fibrillation and PR Interval
Risk prediction of atrial fibrillation: clinical, biological and genetic markers
Patterns of Health Care Use, Treatment &Outcomes in Atrial Fibrillation: PATH-AF
RESEARCH TRAINING AND EDUCATION CORE (CORE D)
AFGen Consortium: Atrial Fibrillation Genomics to Functional Analyses
Advancing Atrial Fibrillation Precision Medicine
Our proposed AHA SFRN Center is entitled "Advancing Atrial Fibrillation Precision Medicine (AAFPM) Center." The AAFPM Center represents 3 interrelated translational projects submitted by a highly collaborative research team with an extraordinarily productive ten-year record of international leadership in atrial fibrillation (AF) research. The Basic Project will further our understanding of the genetic predisposition to AF in ethnic/racial minorities and the molecular underpinnings of top genetic risk loci. The Clinical Project will develop and implement a rational and personalized approach to AF risk estimation that can inform management decisions by combining clinical and genetic risk factors in patients with ischemic stroke. The Population Project will develop models for lifetime risk of AF based on clinical and genetic factors, and subsequently will examine the lifetime risk of complications in individuals with AF. The three projects together will advance our understanding of the genetic and environmental risks and burden of clinically recognized AF and unrecognized AF in the community. Furthermore, we propose to sponsor a Cross-Center AF SFRN Virtual Fellowship to accelerate synergy and collaborations across Centers and Disciplines to train the next generation of translational AF scientists and further the mission of the American Heart Association.
Certificates & Licenses (1)
Certificate of Achievement for the Front-end Coaching Intensive (FECI)
https://www.credly.com/badges/338f120e-f238-48a5-a983-8034ed060f8f/linked_in_profile
Columbia Coaching Center of Excellence (CCOE) is a strategic partnership between Teachers College and the Columbia Business School. FECI focuses on learning and applying 3 foundations (i.e., 4 guiding principles and 4 of 9 core coaching competencies, embedded in a comprehensive 3-phased process - FECI addresses 7 of 9 coaching components) that comprise the Columbia Approach to Executive and Organizational Coaching. FECI is a 5-day intensive offered for 4.2 Continuing Education Units (CEUs).
Awards & Achievements (19)
🏆 Wendy Kline Memorial Award for Outstanding Volunteer Leadership
Description
🏆 Great Communicator Award
Description
🏆 Elected Member
Description
🏆 Excellence in Research Mentoring Award
Description
🏆 Dr. Daniel D. Savage Memorial Science Award
Description
🏆 Functional Genomics and Translational Biology Mentoring Award
Description
🏆 Joel G. Caslowitz, MD Award for Excellence in Teaching–Hospital
Description
🏆 Paul Dudley White Award
Description
🏆 Population Scientist of the Year
Description
🏆 Gold Heart Award
Description
🏆 Distinguished Achievement, GPM Council
Description
🏆 Laennec Clinician/ Educator Lecturer
Description
🏆 Association of American Physicians, Inductee
Description
🏆 Robert Dawson Evans Distinguished Professor of Medicine
Description
🏆 Distinguished Scientist Award
Description
🏆 Diversity, Equity, and Inclusion Award
Description
🏆 Women in Cardiology Mentoring Award
Description
🏆 Dr. Daniel D. Savage Memorial Science Award
Description
🏆 Gender Equity Award
Description
Professional Memberships (1)
American Heart Association (AHA)
Country: United States
Publications (273)
Background.
The genetic contribution to longevity in humans has been estimated to range from 15% to 25%. Only two genes, APOE and FOXO3, have shown association with longevity in multiple independent...
Objectives:
This study sought to evaluate pattern and clinical correlates of change in left ventricular (LV) geometry over a 4-year period in the community; it also assessed whether the pattern of ch...
Context Vascular stiffness increases with advancing age and is a major risk factor for age-related morbidity and mortality. Vascular stiffness and blood pressure pulsatility are related; however, temp...
Atrial fibrillation (AF) is a highly prevalent and costly health problem, with an estimated incidence of 28 per 1000 person-years in the United States and an incremental national cost of $26 billion.1...
Background—
Atrial fibrillation is common among older persons. Catheter ablation is increasingly used in patients for whom medical therapy has failed.
Methods and Results—
We conducted a retrospect...